mortality/aging
• null mice have increased mortality risk, displaying early onset of mortality and more rapid decline after 12 months of age
|
behavior/neurological
• mutants display dystonic tails
|
• aged mice show dyskinesia and a tendency to reduced mobility
|
• significant shortening of hind-limb stride length relative to controls
|
nervous system
• aged mice show reduction in area of substantia nigra
|
• in aged mice, soluble and sarkosyl insoluble tau levels are increased 200% in striatum compared to age-matched controls; tau levels are elevated in cerebral cortex
• tau immunoreactive clusters of dystrophic neurites are increased in hippocampi of 22-month old null animals
• in cultured neurons from aged mice, tau accumulation in neuritic varicosities and perinuclear areas results in disruption of neuronal axons; tau accumulation is higher than in wild-type
|
• ~35% loss of dopaminergic (tyrosine hydroxylase +ve) neurons in substantia nigra relative to controls or young Park2-null mice
|
• cortical neuron degeneration is observed in aged mice
|
• seen in aged mice
|
respiratory system
• postural abnormalities cause respiratory problems
|
skeleton
integument
cellular
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
Parkinson's disease 2 | DOID:0060368 |
OMIM:600116 |
J:125148 |